X0306 4 2020-10-31 0 0001596946 Quotient Ltd QTNT 0000923421 WILKERSON L JOHN C/O GALEN PARTNERS, 680 WASHINGTON BLVD STAMFORD CT 06901 1 0 0 0 Ordinary Shares 7329074 I See Footnote Ordinary Shares 2020-10-31 4 M 0 4421 A 45704 D Ordinary Shares Option (Right to buy) 11.62 2025-10-31 Ordinary Shares 7505 7505 D Ordinary Shares Option (Right to buy) 8.00 2024-04-29 Ordinary Shares 3500 3500 D Ordinary Shares Option (Right to buy) 9.95 2024-10-31 Ordinary Shares 5025 5025 D Ordinary Shares Option (Right to buy) 5.73 2026-10-31 Ordinary Shares 8726 8726 D Ordinary Shares Option (Right to buy) 5.21 2027-10-31 Ordinary Shares 9597 9597 D Ordinary Shares Option (Right to buy) 6.41 2028-10-31 Ordinary Shares 6240 6240 D Restricted Stock Units 2020-10-31 4 M 0 3856 0.00 D Ordinary Shares 3856 0 D Ordinary Shares Option (Right to buy) 7.78 2029-10-31 Ordinary Shares 8158 8158 D Restricted Stock Units 2020-10-31 4 A 0 24176 0.00 A Ordinary Shares 24176 24176 D Restricted Stock Units 2020-10-31 4 A 0 1758 0.00 A Ordinary Shares 1758 1758 D Ordinary Share Option (Right to Buy) 4.55 2020-10-31 4 A 0 13611 0.00 A 2030-10-31 Ordinary Shares 13611 13611 D Restricted Stock Units 2020-10-31 4 A 0 565 0.00 A Ordinary Shares 565 565 D Restricted Stock Units 2020-10-31 4 M 0 565 0.00 D Ordinary Shares 565 0 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. Includes 6,613,590 ordinary shares held of record by Galen V, 564,780 ordinary shares held by Galen International V, and 150,704 ordinary shares held of record by Galen Management, LLC. Mr. Wilkerson is a managing director of Galen Management, LLC, and shares voting and dispositive power over the securities held by Galen V, Galen International V and Galen Management, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein. All 7,505 options have vested and remain exercisable. All 3,500 options have vested and remain exercisable. All 5,025 options have vested and remain exercisable. All 8,726 options have vested and remain exercisable. All 9,597 options have vested and remain exercisable. 4,160 options have vested and remain exercisable, and 2,080 options will vest on October 31, 2021. On October 31, 2019, the Reporting Person was granted 15,424 restricted stock units. All 15,424 restricted stock units have vested and have been exercised. 2,719 options vested on October 31, 2020 and remain exercisable, and the remaining 5,439 options will vest in two equal annual installments on October 31, 2021 and October 31, 2022. On October 31, 2020, the Reporting Person was granted 24,176 restricted stock units, which will vest in four equal installments on January 31, 2021, April 30, 2021, July 31, 2021 and October 31, 2021. On October 31, 2020, the Reporting Person was granted 1,758 restricted stock units, which will vest in four equal installments on January 31, 2021, April 30, 2021, July 31, 2021 and October 31, 2021. The options vest and become exercisable on October 31, 2021. On October 31, 2020, the Reporting Person was granted 565 restricted stock units, all of which vested and were exercised on the grant date. /s/ John L. Wilkerson 2020-11-03